Showing results (1-10 of 53) with videos related to
Sort By:
Pageof 6
Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progres Des Recherches Pharmaceutiques|December 3, 2002
The polyamine oxidase inactivator MDL 72527Nikolaus Seiler, Benoit Duranton, Francis RaulJournal of Cellular and Molecular Medicine|October 6, 2005
Polyamines and apoptosisNikolaus Seiler, Francis RaulCritical Reviews in Clinical Laboratory Sciences|June 15, 2007
Polyamines and the intestinal tractNikolaus Seiler, Francis RaulInternational Journal of Oncology|September 18, 2004
Polyploidisation of metastatic colon carcinoma cells by microtubule and tubulin interacting drugs: effect on proteolytic activity and invasivenessNikolaus Seiler, Yann Schneider, Francine Gossé, et al.International Journal of Oncology|November 8, 2005
Cytotoxicity of the polyamine oxidase inactivator MDL 72527 to cancer cells: comparison with a saturated structural analogueNikolaus Seiler, Jacques Renault, Francine Gossé, et al.Anticancer Research|November 11, 2006
Synergism between apple procyanidins and lysosomotropic drugs: potential in chemopreventionNikolaus Seiler, Mehdi Chaabi, Stamatiki Roussi, et al.Carcinogenesis|March 26, 2005
Chemopreventive properties of apple procyanidins on human colon cancer-derived metastatic SW620 cells and in a rat model of colon carcinogenesisFrancine Gossé, Sylvain Guyot, Stamatiki Roussi, et al.International Journal of Oncology|July 6, 2006
Potentiation of apple procyanidin-triggered apoptosis by the polyamine oxidase inactivator MDL 72527 in human colon cancer-derived metastatic cellsFrancine Gossé, Stamatiki Roussi, Sylvain Guyot, et al.Current Drug Targets|October 11, 2003
Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect. Part 2. Structural analogues and derivativesNikolaus SeilerCurrent Drug Targets|October 11, 2003
Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect. Part 1. Selective enzyme inhibitorsNikolaus SeilerPageof 6